UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) July 2, 2004
Pharmion Corporation
| Delaware | 000-50447 | 84-1521333 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 2525 28th Street, Boulder, Colorado | 80301 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code 720-564-9100
| Item 5. Other Events and Regulation FD Disclosure | ||||||||
| Item 7. Financial Statements, Pro Forma Financial Information And Exhibits | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| Press Release | ||||||||
Item 5. Other Events and Regulation FD Disclosure
On July 2, 2004, Pharmion Corporation, a Delaware corporation (the “Company”), issued a press release announcing that the underwriters of its previously announced offering of common stock have exercised in full their over-allotment option. The press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information And Exhibits
(c) Exhibits
99.1 Press Release, dated July 2, 2004, entitled “Pharmion Corporation Announces Exercise of Over-Allotment Option.”
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PHARMION CORPORATION | ||||
Date: July 2, 2004
|
By: | /s/ Erle T. Mast | ||
| Erle T. Mast | ||||
| Chief Financial Officer | ||||
2